In this free webinar, learn how to integrate multi-omics data from diverse oncology models to identify early biomarkers and de-risk drug development. Attendees will learn strategies for translating complex in vitro and in vivo data into actionable insights for clinical decision-making. The featured speaker will share optimal methods for utilizing advanced patient models like organoids and PDX in precision medicine. Attendees will gain insights into leveraging in silico expertise to enhance biomarker discovery and inform clinical trial strategies.
TORONTO, Dec. 16, 2024 /PRNewswire-PRWeb/ -- Unlock the power of multi-omics data to revolutionize early biomarker discovery in oncology drug development.
In this webinar, the expert speaker will explore the critical role of early biomarker identification in de-risking drug candidates and increasing clinical success rates. As the landscape of preclinical oncology evolves, integrating comprehensive multi-omics analysis with advanced in vitro and in vivo screening models has become essential for generating translatable and actionable insights.
The speaker will delve into the intricate process of leveraging diverse oncology models from traditional cell lines to innovative organoids and patient-derived xenografts (PDX). She will provide valuable guidance on how these advanced patient models can yield deeper insights into precision medicine approaches, drug resistance mechanisms and effective combination therapies. By harnessing the complete potential of multi-omics data, researchers can make informed decisions that align treatments with patient responses.
Throughout the session, she will address the challenges and opportunities in translating complex multi-omics data into meaningful biomarker discoveries. Attendees will learn about state-of-the-art in silico techniques that help decipher the vast amounts of information generated from these studies, enabling them to identify the most promising biomarkers for additional investigation. Do not miss this opportunity to stay at the forefront of oncology drug development.
Register for this webinar to learn how to harness the full potential of multi-omics data and advanced patient models to drive early biomarker discovery.
Join Rajendra Kumari, PhD, Executive Director, Scientific Operations, , for the on Thursday, January 16, 2025, at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit .
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit
For information about hosting a webinar visit
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected],
SOURCE Xtalks; Xtalks
Share this article